Reactive hypoglycemia in binge eating disorder, food addiction, and the comorbid phenotype: unravelling the metabolic drive to disordered eating behaviours.
Binge-eating disorder
Food addiction
Hypoglycemia
OGTT
Obesity
Journal
Journal of eating disorders
ISSN: 2050-2974
Titre abrégé: J Eat Disord
Pays: England
ID NLM: 101610672
Informations de publication
Date de publication:
19 Sep 2023
19 Sep 2023
Historique:
received:
06
06
2023
accepted:
12
09
2023
medline:
20
9
2023
pubmed:
20
9
2023
entrez:
19
9
2023
Statut:
epublish
Résumé
Impaired metabolic response such as blood glucose fast fluctuations may be hypothesized in binge eating disorder (BED) and food addiction (FA) by virtue of the repetitive consumption of highly processed food. Conversely, rapid changes in plasma glucose (i.e., hypoglycemia) may trigger craving for the same food products. The investigation of early glycemic disturbances in BED and FA could enhance the understanding of the metabolic mechanisms involved in the maintenance of the disorders. Present study investigated hypoglycemia events during a 5-h-long oral glucose tolerance test (OGTT) in people with BED, FA, and the comorbid phenotype. Further, the association between the severity of eating psychopathology and the variability in hypoglycaemia events was explored. Two-hundred participants with high weight and no diabetes completed the extended OGTT and were screened for BED, FA, BED-FA, or no-BED/FA. The four groups were compared in hypoglycemia events, OGTT-derived measures, and eating psychopathology. The association between predictors (eating psychopathology), confounders (demographics, metabolic features), and the outcomes (hypoglycemia, early/late hypoglycemia, severe hypoglycemia, reactive hypoglycemia) was examined through logistic regression. Hypoglycemia in general, and reactive hypoglycemia were highly frequent (79% and 28% of the sample, respectively). Hypoglycemia events (< 70 mg/dL) were equally experienced among groups, whilst severe hypoglycemia (< 54 mg/dL) was more frequent in BED at the late stage of OGTT (5 h; χ People with BED or FA are prone to experiencing reactive hypoglycemia; FA severity may predict early and symptomatic hypoglycemia events. This can further reinforce disordered eating behaviours by promoting addictive responses, both biologically and behaviourally. These results inform professionals dealing with eating disorders about the need to refer patients for metabolic evaluation. On the other hand, clinicians dealing with obesity should screen for and address BED and FA in patients seeking care for weight loss. Impairment in blood glucose control may be attended in binge eating disorder (BED) and food addiction (FA), two distinct eating disorders which are characterized by the recurrent consumption of highly palatable food rich in high-glucose index carbohydrates. Conversely, rapid changes in blood glucose, such as hypoglycemia, may intensify craving for high-calorie products, thus reinforcing pathological eating behaviours. This study investigated the presence of hypoglycemia events in people suffering from BED, FA, both, or no eating disorder, and explored whether the severity of eating behaviours correlated with a higher probability of having hypoglycemia. Results showed that people with BED and FA experienced more episodes of symptomatic hypoglycemia than those with obesity but no eating disorder. The severity of binge eating was associated with more severe hypoglycemia events, indicated by lower plasma glucose values. Lastly, people with severe FA were more prone to experiencing early post-meal hypoglycemia accompanied by symptoms. These results inform professionals dealing with eating disorders about the need to refer patients for metabolic evaluation. On the other hand, clinicians dealing with obesity should screen for and address BED and FA in patients seeking care for weight loss.
Sections du résumé
BACKGROUND
BACKGROUND
Impaired metabolic response such as blood glucose fast fluctuations may be hypothesized in binge eating disorder (BED) and food addiction (FA) by virtue of the repetitive consumption of highly processed food. Conversely, rapid changes in plasma glucose (i.e., hypoglycemia) may trigger craving for the same food products. The investigation of early glycemic disturbances in BED and FA could enhance the understanding of the metabolic mechanisms involved in the maintenance of the disorders. Present study investigated hypoglycemia events during a 5-h-long oral glucose tolerance test (OGTT) in people with BED, FA, and the comorbid phenotype. Further, the association between the severity of eating psychopathology and the variability in hypoglycaemia events was explored.
METHODS
METHODS
Two-hundred participants with high weight and no diabetes completed the extended OGTT and were screened for BED, FA, BED-FA, or no-BED/FA. The four groups were compared in hypoglycemia events, OGTT-derived measures, and eating psychopathology. The association between predictors (eating psychopathology), confounders (demographics, metabolic features), and the outcomes (hypoglycemia, early/late hypoglycemia, severe hypoglycemia, reactive hypoglycemia) was examined through logistic regression.
RESULTS
RESULTS
Hypoglycemia in general, and reactive hypoglycemia were highly frequent (79% and 28% of the sample, respectively). Hypoglycemia events (< 70 mg/dL) were equally experienced among groups, whilst severe hypoglycemia (< 54 mg/dL) was more frequent in BED at the late stage of OGTT (5 h; χ
CONCLUSIONS
CONCLUSIONS
People with BED or FA are prone to experiencing reactive hypoglycemia; FA severity may predict early and symptomatic hypoglycemia events. This can further reinforce disordered eating behaviours by promoting addictive responses, both biologically and behaviourally. These results inform professionals dealing with eating disorders about the need to refer patients for metabolic evaluation. On the other hand, clinicians dealing with obesity should screen for and address BED and FA in patients seeking care for weight loss.
Impairment in blood glucose control may be attended in binge eating disorder (BED) and food addiction (FA), two distinct eating disorders which are characterized by the recurrent consumption of highly palatable food rich in high-glucose index carbohydrates. Conversely, rapid changes in blood glucose, such as hypoglycemia, may intensify craving for high-calorie products, thus reinforcing pathological eating behaviours. This study investigated the presence of hypoglycemia events in people suffering from BED, FA, both, or no eating disorder, and explored whether the severity of eating behaviours correlated with a higher probability of having hypoglycemia. Results showed that people with BED and FA experienced more episodes of symptomatic hypoglycemia than those with obesity but no eating disorder. The severity of binge eating was associated with more severe hypoglycemia events, indicated by lower plasma glucose values. Lastly, people with severe FA were more prone to experiencing early post-meal hypoglycemia accompanied by symptoms. These results inform professionals dealing with eating disorders about the need to refer patients for metabolic evaluation. On the other hand, clinicians dealing with obesity should screen for and address BED and FA in patients seeking care for weight loss.
Autres résumés
Type: plain-language-summary
(eng)
Impairment in blood glucose control may be attended in binge eating disorder (BED) and food addiction (FA), two distinct eating disorders which are characterized by the recurrent consumption of highly palatable food rich in high-glucose index carbohydrates. Conversely, rapid changes in blood glucose, such as hypoglycemia, may intensify craving for high-calorie products, thus reinforcing pathological eating behaviours. This study investigated the presence of hypoglycemia events in people suffering from BED, FA, both, or no eating disorder, and explored whether the severity of eating behaviours correlated with a higher probability of having hypoglycemia. Results showed that people with BED and FA experienced more episodes of symptomatic hypoglycemia than those with obesity but no eating disorder. The severity of binge eating was associated with more severe hypoglycemia events, indicated by lower plasma glucose values. Lastly, people with severe FA were more prone to experiencing early post-meal hypoglycemia accompanied by symptoms. These results inform professionals dealing with eating disorders about the need to refer patients for metabolic evaluation. On the other hand, clinicians dealing with obesity should screen for and address BED and FA in patients seeking care for weight loss.
Identifiants
pubmed: 37726785
doi: 10.1186/s40337-023-00891-z
pii: 10.1186/s40337-023-00891-z
pmc: PMC10507855
doi:
Types de publication
Journal Article
Langues
eng
Pagination
162Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Biol Psychiatry. 2013 May 1;73(9):804-10
pubmed: 23098895
J Clin Endocrinol Metab. 2013 May;98(5):1845-59
pubmed: 23589524
Diabetes Metab. 2000 Nov;26(5):337-51
pubmed: 11119013
Am J Clin Nutr. 2021 Feb 2;113(2):274-276
pubmed: 33448277
Soc Psychiatry Psychiatr Epidemiol. 2022 Jul;57(7):1491-1503
pubmed: 35044479
Diabet Med. 1994 Apr;11(3):286-92
pubmed: 8033528
Clin Chem. 2018 Jan;64(1):64-71
pubmed: 29158252
Nutrients. 2014 Sep 16;6(9):3653-71
pubmed: 25230209
Int J Eat Disord. 2017 Jan;50(1):58-65
pubmed: 27642179
Front Endocrinol (Lausanne). 2017 Aug 30;8:218
pubmed: 28912753
Obesity (Silver Spring). 2019 Apr;27(4):629-635
pubmed: 30900406
Eat Behav. 2007 Jan;8(1):31-8
pubmed: 17174849
Medicine (Baltimore). 2015 Dec;94(52):e2098
pubmed: 26717356
Clin Nutr. 2023 May;42(5):717-721
pubmed: 36996685
Am J Physiol. 1991 Jan;260(1 Pt 1):E67-74
pubmed: 1987794
J Behav Med. 2016 Apr;39(2):320-32
pubmed: 26686376
Diabetes Metab Syndr Obes. 2020 Dec 02;13:4717-4726
pubmed: 33293845
J Pers Med. 2021 Apr 07;11(4):
pubmed: 33916952
Nutrients. 2019 Nov 03;11(11):
pubmed: 31684127
Surg Obes Relat Dis. 2013 Sep-Oct;9(5):802-8
pubmed: 23260807
Nutrients. 2023 Jan 10;15(2):
pubmed: 36678225
J Clin Endocrinol Metab. 2015 Dec;100(12):4441-6
pubmed: 26502359
Nutrients. 2021 Sep 02;13(9):
pubmed: 34578968
Nutrients. 2020 Nov 20;12(11):
pubmed: 33233694
Clin Psychol Rev. 2016 Mar;44:125-139
pubmed: 26879210
J Clin Endocrinol Metab. 2009 Mar;94(3):709-28
pubmed: 19088155
Int J Eat Disord. 2012 Jul;45(5):657-63
pubmed: 22684991
J Clin Invest. 2011 Oct;121(10):4161-9
pubmed: 21926468
Obesity (Silver Spring). 2016 Oct;24(10):2064-9
pubmed: 27558207
Front Psychiatry. 2022 Jan 10;12:824936
pubmed: 35082706
Pediatr Pulmonol. 2020 Dec;55(12):3391-3399
pubmed: 32955169
Endocr Metab Immune Disord Drug Targets. 2023;23(3):283-293
pubmed: 35761485
Pediatr Endocrinol Rev. 2011 Sep;9(1):463-73; quiz 474-5
pubmed: 22783644
J Clin Med. 2019 Feb 01;8(2):
pubmed: 30717125
Nutrients. 2021 Aug 13;13(8):
pubmed: 34444940
Eur J Endocrinol. 2017 Jul;177(1):R37-R47
pubmed: 28381450
Appetite. 2021 Nov 1;166:105442
pubmed: 34111480
Drug Discov Ther. 2015 Dec;9(6):380-5
pubmed: 26781921
Arch Gen Psychiatry. 2011 Aug;68(8):808-16
pubmed: 21464344
Eur Eat Disord Rev. 2018 Nov;26(6):645-656
pubmed: 30353597
Hum Reprod. 2016 May;31(5):1105-12
pubmed: 27008892
Int J Eat Disord. 2007 Jan;40(1):67-71
pubmed: 17080451
Psychol Addict Behav. 2016 Feb;30(1):113-21
pubmed: 26866783
Psychiatr Pol. 2017 Apr 30;51(2):247-259
pubmed: 28581535
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Curr Neuropharmacol. 2019;17(6):526-538
pubmed: 30406740
Eat Weight Disord. 2022 Aug;27(6):1963-1970
pubmed: 35041154
Nutrients. 2014 Dec 31;7(1):223-38
pubmed: 25558907
Front Endocrinol (Lausanne). 2018 Nov 09;9:661
pubmed: 30473679
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Eur Eat Disord Rev. 2016 Mar;24(2):174-8
pubmed: 26147590
Appetite. 2019 Oct 1;141:104317
pubmed: 31185252
Am J Clin Nutr. 2010 Jun;91(6):1568-73
pubmed: 20427731
Obesity (Silver Spring). 2014 Nov;22(11):2441-9
pubmed: 25136837
Psychopharmacology (Berl). 2004 Apr;173(1-2):217-20
pubmed: 14726998
Diabetes Care. 2017 Jan;40(Suppl 1):S4-S5
pubmed: 27979887
Psychoneuroendocrinology. 2005 Jun;30(5):496-504
pubmed: 15721060
Neuropharmacology. 2011 Dec;61(7):1123-8
pubmed: 21420985
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
Physiol Behav. 2008 Aug 6;94(5):696-9
pubmed: 18534636
Diabetes Care. 2003 Nov;26(11):3160-7
pubmed: 14578255
Addict Behav. 1982;7(1):47-55
pubmed: 7080884
PLoS One. 2015 Feb 18;10(2):e0117959
pubmed: 25692302
Sisli Etfal Hastan Tip Bul. 2019 Aug 28;53(3):215-220
pubmed: 32377086
Biol Psychiatry. 2007 Feb 1;61(3):348-58
pubmed: 16815322
Eat Behav. 2018 Jan;28:8-15
pubmed: 29202335
Metabolites. 2023 Feb 06;13(2):
pubmed: 36837857
Biol Psychiatry. 2018 Sep 1;84(5):345-354
pubmed: 29859631
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Nutrients. 2014 Oct 21;6(10):4552-90
pubmed: 25338274
Eat Weight Disord. 2017 Sep;22(3):527-533
pubmed: 28780748
Presse Med. 2016 Dec;45(12 Pt 1):1154-1163
pubmed: 27211587
Diabetes. 1981 Jun;30(6):465-70
pubmed: 7227659
Metabolism. 1985 Sep;34(9):826-31
pubmed: 3897769
Appetite. 2023 Apr 1;183:106475
pubmed: 36716820